Aileron Therapeutics, Inc.ALRNNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-22.29M
Near historical average
Average (9y)
$-21.78M
Historical baseline
Range
High:$-11.80M
Low:$-32.35M
CAGR
+7.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-22.29M | -12.5% |
| 2023 | $-19.81M | +20.3% |
| 2022 | $-24.86M | -4.0% |
| 2021 | $-23.91M | -16.7% |
| 2020 | $-20.48M | +23.1% |
| 2019 | $-26.63M | +17.7% |
| 2018 | $-32.35M | -56.5% |
| 2017 | $-20.67M | -37.7% |
| 2016 | $-15.01M | -27.2% |
| 2015 | $-11.80M | - |